We are live on
!
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$81.9M
1-Year Est. Return
26.59%
This Fund
S&P 500
This Quarter
Est. Return
-3.38%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$43.6M
AUM Growth
-$446M
(-91%)
Cap. Flow
-$442M
Cap. Flow
% of AUM
-1,013.48%
Top 10 Holdings %
Top 10 Hldgs %
28.16%
Holding
580
New
77
Increased
4
Reduced
27
Closed
472
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.24M |
| 2 |
TSMC
TSM
|
+$1.13M |
| 3 |
NuScale Power
SMR
|
+$1.11M |
| 4 |
Trade Desk
TTD
|
+$1.02M |
| 5 |
Microchip Technology
MCHP
|
+$910K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$5.39M |
| 2 |
Accenture
ACN
|
+$5.35M |
| 3 |
CRWV
CoreWeave
CRWV
|
+$4.97M |
| 4 |
Robinhood
HOOD
|
+$4.87M |
| 5 |
Expedia Group
EXPE
|
+$4.81M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.63% |
| 2 | Healthcare | 13.02% |
| 3 | Communication Services | 12.94% |
| 4 | Consumer Discretionary | 11.11% |
| 5 | Industrials | 9.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Broadcom
AVGO
$1.82T
| – | – |
-8,800
| Closed | -$2.9M |
|
152
Avantor
AVTR
$7.81B
| – | – |
-18,500
| Closed | -$231K |
|
153
American Express
AXP
$223B
| – | – |
-1,400
| Closed | -$465K |
|
154
Axalta
AXTA
$7.01B
| – | – |
-26,200
| Closed | -$750K |
|
155
AstraZeneca
AZN
$263B
| – | – |
-1,565
| Closed | -$240K |
|
156
Alibaba
BABA
$269B
| – | – |
-2,000
| Closed | -$357K |
|
157
BioCryst Pharmaceuticals
BCRX
$2.37B
| – | – |
-17,400
| Closed | -$132K |
|
158
Franklin Resources
BEN
$16.9B
| – | – |
-11,141
| Closed | -$258K |
|
159
Bright Horizons
BFAM
$3.99B
| – | – |
-16,200
| Closed | -$1.76M |
|
160
Biogen
BIIB
$29.9B
| – | – |
-5,100
| Closed | -$714K |
|
161
BILL Holdings
BILL
$4.33B
| – | – |
-12,800
| Closed | -$678K |
|
162
Bio-Rad Laboratories Class A
BIO
$8.42B
| – | – |
-2,275
| Closed | -$638K |
|
163
BJ's Restaurants
BJRI
$1.41B
| – | – |
-15,900
| Closed | -$485K |
|
|
BNY
164
Bank of New York Mellon
BNY
$108B
| – | – |
-10,209
| Closed | -$1.11M |
|
165
Blue Bird Corp
BLBD
$2.41B
| – | – |
-10,300
| Closed | -$593K |
|
166
Builders FirstSource
BLDR
$7.84B
| – | – |
-2,000
| Closed | -$243K |
|
167
Bank of Montreal
BMO
$125B
| – | – |
-3,174
| Closed | -$413K |
|
168
BioMarin Pharmaceuticals
BMRN
$11.5B
| – | – |
-20,800
| Closed | -$1.13M |
|
169
Brookfield
BN
$102B
| – | – |
-7,200
| Closed | -$329K |
|
170
Bristol-Myers Squibb
BMY
$127B
| – | – |
-25,500
| Closed | -$1.15M |
|
171
Scotiabank
BNS
$106B
| – | – |
-27,190
| Closed | -$1.76M |
|
172
Box
BOX
$4.02B
| – | – |
-10,761
| Closed | -$347K |
|
173
Berkshire Hathaway Class B
BRK.B
$1.07T
| – | – |
-5,000
| Closed | -$2.51M |
|
174
Bruker
BRKR
$9.2B
| – | – |
-35,200
| Closed | -$1.14M |
|
175
Dutch Bros
BROS
$8.78B
| – | – |
-35,800
| Closed | -$1.87M |
|
Similar funds
KL
FWS
FRIHG
AGFVA
1C
MP
FLC
APW
Bayesian Capital Management's Q4 2025 Portfolio in Review
As of Q4 2025, Bayesian Capital Management held 580 positions worth $43.6M, down 91% from $490M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Bayesian Capital Management withdrew a net $442M in Q4 2025, closing 472 positions and reducing 27 holdings. Its most notable exit was Boston Scientific, an estimated $5.39M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Bayesian Capital Management opened a new position in JPMorgan Chase worth $1.29M.
- Bayesian Capital Management's largest Q4 2025 buy was JPMorgan Chase: 4,000 shares worth $1.29M.
- Bayesian Capital Management added most to TSMC in Q4 2025, an estimated $1.13M increase.
- Bayesian Capital Management's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $4.54M.
- Bayesian Capital Management fully exited Boston Scientific in Q4 2025, selling an estimated $5.39M.
- Bayesian Capital Management's ten largest holdings make up 28% of its $43.6M portfolio in Q4 2025.
- Bayesian Capital Management opened 77 new positions and closed 472 in Q4 2025.
- Bayesian Capital Management's portfolio value fell 91% quarter-over-quarter to $43.6M.
Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.